'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours
Kiran Mazumdar-Shaw has reaffirmed that Biocon is not for sale, despite market rumours. The company is focusing on reducing debt, expanding into biosimilars, and capitalising on global opportunities, including the US Bio Secure Act.